A new study using our next generation TCR analysis was awarded a "Young Investigator Award" at the International Conference of Cancer Immunotherapy and Macrophages 2015 (ICCIM2015).
This study (Koji Nagaoka et al., Department of Immunotherapeutics, The University of Tokyo Hospital, Japan), revealed that characteristics and diversity of the CD8+ tumor infiltrating T lymphocytes (TILs) in spontaneously regressing or progressing tumor mouse model.